3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Bevacizumab
20
Paclitaxel
18
Carboplatin
15
pembrolizumab
14
Specimen Handling
14
Magnetic Resonance Spectroscopy
12
liposomal doxorubicin
11
olaparib
10
Cyclophosphamide
10
Gemcitabine
9
fludarabine
8
Topotecan
8
Biopsy
8
niraparib
6
Nivolumab
6
Taxes
5
Immunoglobulin G
5
Fulvestrant
5
Disulfides
5
palbociclib
4
aldesleukin
4
Oxaliplatin
4
Doxorubicin
4
trastuzumab deruxtecan
3
mirvetuximab soravtansine
3
binimetinib
3
Leucovorin
3
Fluorouracil
3
Cisplatin
3
AZD5305
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
LY3023414
×
30 days
×
Clear all
No trials found.